Fujikawa Ko, Takasugi Nobuhiro, Goto Tadao, Minatoguchi Shinya
Department of Internal Medicine, Shirotori National Health Insurance Hospital, Gifu, Japan.
Division of Cardiovascular Medicine, Gifu University Hospital, Gifu, Japan.
Can J Cardiol. 2017 Apr;33(4):554.e15-554.e16. doi: 10.1016/j.cjca.2016.12.017. Epub 2016 Dec 29.
An 87-year-old man with persistent atrial fibrillation experienced heartburn and dysphagia at 2 years 9 months after initiation of dabigatran. An esophagogastroduodenoscopy demonstrated multiple longitudinal white plaques with ulcers in the narrowed midesophagus compressed between the left atrium and the tortuous aorta. We speculate that the esophageal stenosis contributed to stasis of dabigatran within the esophagus, resulting in prolonged mucosal contact with the caustic contents of the drug. Progressive enlargement of the left atrium may have led to the late onset of the potentially serious complication.
一名87岁持续性心房颤动男性在开始服用达比加群2年9个月后出现烧心和吞咽困难。食管胃十二指肠镜检查显示,在左心房和迂曲主动脉之间受压的食管中段狭窄处有多个纵向白色斑块伴溃疡。我们推测,食管狭窄导致达比加群在食管内淤滞,致使药物腐蚀性成分与黏膜的接触时间延长。左心房的逐渐增大可能导致了这一潜在严重并发症的迟发。